Thank you to the following exhibitors for supporting the 2025 44th Annual Internal Medicine Review.
By clicking the links, you are leaving this education space.
Boehringer-Ingelheim | |
Pfizer, Inc | |
Alexion AstraZeneca Rare Disease | |
Verona Pharma | |
Elitera Mastery Institute |